Birchview Capital
Latest statistics and disclosures from Birchview Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BMY, AXDX, QDEL, AWH, NBIX, and represent 67.59% of Birchview Capital's stock portfolio.
- Added to shares of these 6 stocks: QDEL, BMY.R, ACAD, ALBO, AMRN, BMY.
- Reduced shares in these 4 stocks: GILD, AWH, NARI, WKHS.
- Sold out of its positions in GILD.
- Birchview Capital was a net buyer of stock by $2.0M.
- Birchview Capital has $150M in assets under management (AUM), dropping by -9.54%.
Tip: Access up to 7 years of quarterly data
Positions held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Birchview Capital
Companies in the Birchview Capital portfolio as of the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 32.0 | $48M | 794k | 60.29 | ||
| Accelr8 Technology (AXDX) | 15.6 | $23M | 2.2M | 10.66 | ||
| Quidel Corporation (QDEL) | 8.6 | $13M | +15% | 59k | 219.37 | |
| Aspira Womens Health (AWH) | 6.4 | $9.5M | -6% | 3.1M | 3.08 | |
| Neurocrine Biosciences (NBIX) | 5.0 | $7.5M | 78k | 96.15 | ||
| ACADIA Pharmaceuticals (ACAD) | 2.8 | $4.2M | +9% | 102k | 41.25 | |
| Bluebird Bio (BLUE) | 2.2 | $3.2M | 60k | 53.95 | ||
| Biogen Idec (BIIB) | 2.1 | $3.1M | 11k | 283.64 | ||
| Bmy Cvr Rts 03/31/21 Right (BMY.R) | 1.8 | $2.7M | +70% | 1.2M | 2.25 | |
| Karyopharm Therapeutics (KPTI) | 1.6 | $2.5M | 168k | 14.60 | ||
| Acceleron Pharma (XLRN) | 1.4 | $2.1M | 19k | 112.52 | ||
| Soleno Therapeutics | 1.4 | $2.1M | 827k | 2.51 | ||
| Oxford Immunotec Global (OXFD) | 1.3 | $2.0M | 170k | 11.70 | ||
| Albireo Pharma (ALBO) | 1.3 | $1.9M | +20% | 58k | 33.36 | |
Setup an alertBirchview Capital will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Masimo Corporation (MASI) | 1.3 | $1.9M | 8.0k | 236.00 | ||
| United Therapeutics Corporation (UTHR) | 1.2 | $1.8M | 18k | 101.00 | ||
| Arena Pharmaceuticals (ARNA) | 1.1 | $1.6M | 22k | 74.77 | ||
| Chemocentryx (CCXI) | 1.1 | $1.6M | 30k | 54.80 | ||
| Myokardia (MYOK) | 0.9 | $1.4M | 10k | 136.30 | ||
| Contrafect | 0.9 | $1.3M | 256k | 5.28 | ||
| Amarin Corp Spons Adr New (AMRN) | 0.8 | $1.3M | +15% | 300k | 4.21 | |
| Equitrans Midstream Corp (ETRN) | 0.8 | $1.1M | 133k | 8.46 | ||
| Harrow Health (HROW) | 0.7 | $1.0M | 180k | 5.59 | ||
| Corcept Therapeutics Incorporated (CORT) | 0.6 | $870k | 50k | 17.40 | ||
| Epizyme (EPZM) | 0.6 | $835k | 70k | 11.93 | ||
| Vanda Pharmaceuticals (VNDA) | 0.5 | $773k | 80k | 9.66 | ||
| ImmunoGen (IMGN) | 0.5 | $684k | 190k | 3.60 | ||
| Stoke Therapeutics (STOK) | 0.4 | $670k | 20k | 33.50 | ||
| Biohaven Pharmaceutical Holding (BHVN) | 0.4 | $650k | 10k | 65.00 | ||
| Amicus Therapeutics (FOLD) | 0.4 | $537k | 38k | 14.13 | ||
| Inari Medical Ord (NARI) | 0.3 | $483k | -30% | 7.0k | 69.00 | |
| Xencor (XNCR) | 0.3 | $477k | 12k | 38.78 | ||
| Continental Resources (CLR) | 0.3 | $474k | 39k | 12.28 | ||
| G1 Therapeutics (GTHX) | 0.3 | $462k | 40k | 11.55 | ||
| Progyny (PGNY) | 0.3 | $441k | 15k | 29.40 | ||
| Translate Bio (TBIO) | 0.3 | $408k | 30k | 13.60 | ||
| Tg Therapeutics (TGTX) | 0.3 | $401k | 15k | 26.73 | ||
| Kalvista Pharmaceuticals (KALV) | 0.3 | $378k | 30k | 12.60 | ||
| Arvinas Ord (ARVN) | 0.2 | $354k | 15k | 23.60 | ||
| Intercept Pharmaceuticals In (ICPT) | 0.2 | $344k | 8.3k | 41.45 | ||
| Pioneer Natural Resources (PXD) | 0.2 | $327k | 3.8k | 86.05 | ||
| Voyager Therapeutics (VYGR) | 0.2 | $320k | 30k | 10.67 | ||
| Inflarx Nv (IFRX) | 0.2 | $298k | 70k | 4.26 | ||
| Encana Corporation (OVV) | 0.2 | $280k | 34k | 8.15 | ||
| Odonate Therapeutics Ord (ODT) | 0.2 | $269k | 20k | 13.45 | ||
| Apellis Pharmaceuticals (APLS) | 0.2 | $241k | 8.0k | 30.12 | ||
| Workhorse Group Inc ordinary shares (WKHS) | 0.1 | $202k | -46% | 8.0k | 25.25 | |
| Dicerna Pharmaceuticals (DRNA) | 0.1 | $180k | 10k | 18.00 | ||
| Yield10 Bioscience | 0.1 | $147k | 19k | 7.76 | ||
| BioCryst Pharmaceuticals (BCRX) | 0.0 | $69k | 20k | 3.45 | ||
Past Filings by Birchview Capital
SEC 13F filings are viewable for Birchview Capital going back to 2014
- Birchview Capital 2020 Q3 restated filed Nov. 12, 2020
- Birchview Capital 2020 Q3 filed Nov. 12, 2020
- Birchview Capital 2020 Q2 restated filed Sept. 25, 2020
- Birchview Capital 2020 Q2 filed Aug. 10, 2020
- Birchview Capital 2020 Q1 filed May 12, 2020
- Birchview Capital 2019 Q4 filed Feb. 12, 2020
- Birchview Capital 2019 Q3 filed Nov. 12, 2019
- Birchview Capital 2019 Q2 filed Aug. 6, 2019
- Birchview Capital 2019 Q1 filed May 3, 2019
- Birchview Capital 2018 Q4 filed Feb. 6, 2019
- Birchview Capital 2018 Q3 filed Nov. 1, 2018
- Birchview Capital 2018 Q2 filed Aug. 2, 2018
- Birchview Capital 2018 Q1 filed May 7, 2018
- Birchview Capital 2017 Q4 filed Feb. 2, 2018
- Birchview Capital 2017 Q3 filed Nov. 2, 2017
- Birchview Capital 2017 Q2 filed Aug. 8, 2017